West End Salon and Medspa weight loss program uses semaglutide or Tirzepatide and Retatrutide. The program begins with an initial consultation with the nurse practitioner, and labs are drawn to ensure all organs are working properly. Medications and supplies are included.
Semaglutide is a glucagon-like peptide-1 receptor agonist. It mimics the action of the incretin GL-1 by increasing the production of insulin. Semaglutide for weight suppresses your appetite and works in the brain’s areas that regulate appetite and food intake. In addition to using Semaglutide, an exercise program and reduced caloric intake will aid in weight loss goals and long-term management.
We also use Tirzepatide in our weight loss program. Tirzepatide, known as Mounjaro, was approved by the FDA in 2022 to treat type 2 diabetes. Tirzepatide is a dual GIP and GLP-1 receptor agonist medication used to treat type 2 diabetes and obesity by enhancing insulin secretion, reducing appetite, and slowing digestion, offering benefits such as improved blood sugar control, reduced cardiovascular risk factors, and significant weight loss—often averaging 15–20% of total body weight in clinical trials, especially when paired with healthy lifestyle habits.
We also use Retatrutide. has shown promising results in helping people lose significant weight, with studies suggesting an average loss of 15-20% of body weight. It works by targeting hormones that control hunger and metabolism, potentially improving heart health, lowering cholesterol, and boosting energy levels. Retatrutide may also help reduce visceral fat, lower cholesterol levels, and improve overall cardiovascular health, potentially offering a multi-faceted approach to managing obesity and metabolic disorders.
It’s not clear whether it passes into human milk. Due to potential risk to the infant, caution is advised, and other options are usually preferred. If you're pregnant, trying to conceive, or breastfeeding, it's safest to avoid these medications for now unless specifically advised otherwise by a specialist. Alternatives may be available depending on the condition being treated (e.g., diabetes or obesity).
It, of course, depends on your body weight, your health, and how much product your take. Semaglutide (Wegovy) can lead to an average weight loss of about 15% of body weight over 68 weeks, while tirzepatide (Zepbound) shows greater results, with around 20–22.5% weight loss over 72 weeks. Retatrutide, still in clinical trials, has shown the most impressive outcomes so far, with up to 24.2% body weight loss in just 48 weeks. All three drugs work by targeting hormones that regulate appetite and metabolism—semaglutide activates GLP-1 receptors, tirzepatide targets both GLP-1 and GIP, and retatrutide hits GLP-1, GIP, and glucagon receptors. These percentages are averages from clinical trials, and individual results can vary based on factors like dose, lifestyle, and tolerance to side effects such as nausea or GI upset. As you increase your dosage, you can lose more weight.
Yes, stopping semaglutide, tirzepatide, or retatrutide can lead to some weight regain, as the appetite-suppressing and metabolic effects wear off. Studies show that people may regain a portion of the weight lost, but this is not a rebound effect—it's simply the body returning to its natural patterns. However, with the right support—like healthy eating, regular activity, and ongoing lifestyle changes—it’s absolutely possible to maintain much of the progress. These medications work best as part of a long-term approach to health, and even if you stop, the habits and knowledge you gain while on them can help you stay on track.
You may experience nausea, vomiting, diarrhea, abdominal pain, and constipation. If you have heart problems, these injections could cause a problem. Other less common side effects include elevated heart rate, allergic reactions, low blood sugar, pancreatitis, thyroid tumors, and kidney problems.
Semaglutide, tirzepatide, and retatrutide are all administered as once-weekly subcutaneous injections, typically given in the abdomen, thigh, or upper arm. Semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes) comes in a prefilled pen, and although an oral version (Rybelsus) exists, it’s only approved for diabetes, not weight loss. Tirzepatide (Zepbound for weight loss and Mounjaro for diabetes) is also injected weekly using a pen device, with dosing gradually increased to minimize side effects. Retatrutide, still in clinical trials, is being studied in the same weekly injection format. All three require consistent use and proper injection technique to ensure effectiveness and minimize side effects.
Dosages are based on your health conditions and your response to the treatments. We will start at a low dose and gradually increase your intake. These injections are used for about six months, and you will see fantastic results.
1. Pregnant or breastfeeding women
– Not recommended due to potential risks to the baby and lack of safety data.
2. People with a history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
– These medications carry a warning for increased risk of thyroid C-cell tumors (seen in animal studies).
3. People with a history of pancreatitis
– Use with caution, as these drugs may increase the risk of pancreatitis in some individuals.
4. People with severe gastrointestinal issues
– Conditions like gastroparesis (delayed stomach emptying) can worsen with these meds, which slow digestion.
5. Those allergic to any components of the medication
– Rare, but anyone with a known hypersensitivity to ingredients should avoid them.
6. People with type 1 diabetes or needing rapid weight loss due to illness
– These drugs are not intended for type 1 diabetes or acute weight loss situations like cancer-related cachexia.
7. Children and adolescents (unless specifically approved)
– Most are only approved for adults, though semaglutide (Wegovy) was recently approved for teens aged 12+ with obesity.
⚠️ Use with caution if: You have kidney or liver issues (dosing and monitoring may be needed)You're taking insulin or sulfonylureas (may need dose adjustments to prevent low blood sugar)
Important: A full medical evaluation is key before starting any of these treatments. They’re powerful tools, but not one-size-fits-all — and safety always comes first.
Our complimentary consultation is the perfect way to discuss and sign a personalized treatment plan that works for you and your goals. Simply complete this form to request your consultation either in person or remotely from the comforts of your home and will get in touch with you soon to arrange a time that fits your busy schedule.